HEPHAISTOS-Pharma appoints Stephan Braun as Chief Medical Officer to lead clinical development strategyHEPHAISTOS-Pharma appoints Stephan Braun as Chief Medical Officer to lead clinical development strategy
GenoSafe advances CLIA pathway for transatlantic ATMP developmentGenoSafe advances CLIA pathway for transatlantic ATMP development
Point Launches Third-Party Origination Channel for Brokers; Hires Samuel Bjelac as Head of WholesaleExpanded partners program gives mortgage lenders more options to help their customers access home equity
Yimutian Inc. Announces Receipt of Nasdaq Notification Regarding Market Value of Listed Securities Requirement and Nasdaq Delisting Notice Subject to Hearing RequestBEIJING, May 19, 2026 (GLOBE NEWSWIRE) -- Yimutian Inc. (Nasdaq: YMT) (“Yimutian” or the “Company”), a leading agricultural digital service company in China, today announced that it received two written notifications from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) on May 13, 2026, the details of which are described below.
Transaction in Own SharesTransaction in Own Shares
LexinFintech Holdings Ltd. to Report First Quarter 2026 Unaudited Financial Results on May 25, 2026 (Beijing time)SHENZHEN, China, May 19, 2026 (GLOBE NEWSWIRE) -- LexinFintech Holdings Ltd. (“Lexin” or the “Company”) (
NASDAQ: LX), a leading technology-empowered personal financial service enabler in China, today announced that it will report its unaudited financial results for the first quarter ended March 31, 2026, before the U.S. market opens on May 25, 2026.
BROAD ARROW CELEBRATES STYLE AND PERFORMANCE AT €40.8M CONCORSO D’ELEGANZA VILLA D’ESTE AUCTIONBROAD ARROW CONCORSO D’ELEGANZA VILLA D’ESTE AUCTION ACHIEVES TOTAL SALES OF €40.8 MILLION WITH A SELL-THROUGH RATE OF 87 PERCENT | FERRARI MODELS PROVE TO BE THE STARS OF THE TWO-DAY SALE INCLUDING A 2023 DAYTONA SP3 THAT SOLD FOR €6.250.000, A 1990 F40 AT €2.931.250 AND A 1968 330 GTS THAT ACHIEVED €1.918.750 | 2015 PORSCHE 918 SPYDER WEISSACH PACKAGE SOLD FOR €2.256.250 WITH AUCTION FAVOURITE, A 1957 MERCEDES-BENZ 300 SL GULLWING COUPE, ACHIEVING €1.637.500 | UNIQUE ITALIAN COLLECTOR CARS GENERATE GLOBAL INTEREST INCLUDING A 1963 FIAT 600 TORPEDO MARINA BY VIGNALE AND A FIAT FACTORY VIP VISITORS BUS BY BERTONE
Mabylon Reports Positive Phase Ia Results in MY006 Peanut Allergy Trial and Initiates Phase Ib Patient Part of the Study; Advances Tree Pollen Allergy Program MY010 toward Clinical DevelopmentSchlieren/Zurich, Switzerland, May 19, 2026 - Mabylon AG, a leader in the discovery and development of human-derived, half-life extended multi-specific antibodies, today reported preliminary positive Phase Ia data demonstrating a favorable safety profile of its lead candidate MY006 in an ongoing first-in-human trial. Mabylon also announced the initiation of dosing of individuals with peanut allergy in the Phase Ib part of the study. The Company’s antibodies are designed to neutralize disease-relevant allergens, thereby preventing allergic reactions.
ESET supercharges AI innovation with investment to address rapidly expanding attack surfaceBERLIN, May 19, 2026 (GLOBE NEWSWIRE) -- ESET World -- ESET, a global leader in cybersecurity, today announced an investment of €40 million into the future of AI-powered cybersecurity, as the company warns of a rapidly emerging new attack surface driven by autonomous and agentic AI systems.
Anaveon Strengthens Leadership Team with Appointments of Eric Zanelli as Chief Scientific Officer and Jill Jene as Chief Business OfficerBASEL, Switzerland, May 19, 2026 (GLOBE NEWSWIRE) -- Anaveon, a late-stage biotechnology company pioneering precision biologics to reprogram the immune system for the treatment of autoimmune and inflammatory diseases, today announced the appointments of Eric Zanelli, Ph.D., as Chief Scientific Officer and Jill Jene, Ph.D., MBA, as Chief Business Officer. These strategic C-suite additions bring deep scientific, translational, and business development expertise to accelerate Anaveon’s clinical advancement and pipeline expansion.
Futu to Report First Quarter 2026 Financial Results on May 28, 2026HONG KONG, May 19, 2026 (GLOBE NEWSWIRE) -- Futu Holdings Limited (“Futu” or the “Company”) (Nasdaq: FUTU), a leading tech-driven online brokerage and wealth management platform, today announced that it will report its financial results for the first quarter ended March 31, 2026, before U.S. markets open on May 28, 2026.
ESET reaffirms its global market presence with new European and Asian officesBERLIN, May 19, 2026 (GLOBE NEWSWIRE) -- (ESET World 2026) -- ESET, a global leader in cybersecurity solutions and the largest European cybersecurity vendor*, today, at ESET World 2026, announced the opening of its ESET France, ESET Netherlands, and ESET India branches, growing its local presence and market opportunities in those regions.
Unaudited Preliminary Results for the Year Ended December 31, 2025LONDON and PHILADELPHIA, May 19, 2026 (GLOBE NEWSWIRE) -- Avacta Therapeutics (AIM: AVCT, “the Company”, “Avacta”), a clinical stage biopharmaceutical company developing pre|CISION, a tumor-activated oncology delivery platform today published its unaudited preliminary results for the 12 months ended December 31, 2025 ("FY25").
Stellantis Announces Groundbreaking, Small and Affordable E-Car ProjectStellantis Announces Groundbreaking, Small and Affordable E-Car Project
Khondrion Announces First Patient Dosed in Phase II Study Targeting Debilitating Post-COVID FatigueSON4PEM trial advances development of sonlicromanol, aiming to address chronic fatigue in Post-COVID patients with post-exertional malaise
Progress on share buyback programmeProgress on share buyback programme
ONWARD Medical to Announce First Quarter 2026 Results on May 26, 2026EINDHOVEN, The Netherlands, May 19, 2026 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD – US ADR: ONWRY), the leading neurotechnology company pioneering therapies to restore movement, function, and independence in people with spinal cord injury and other movement disabilities, today announced that it will release its first quarter 2026 financial results and host a webcast to provide a comprehensive business update on May 26, 2026.
CMB.TECH announces Q1 2026 resultsCMB.TECH ANNOUNCES Q1 2026 RESULTSFIRING ON ALL CYLINDERS
Andreas P. Stöcklin Appointed to Lead FTI Consulting’s Transactions Offering in Continental EuropeMUNICH, May 19, 2026 (GLOBE NEWSWIRE) -- FTI Consulting, Inc. (
NYSE: FCN) today announced the appointment of M&A and transactions expert Andreas P. Stöcklin as a Senior Managing Director in the firm’s Corporate Finance segment.
Kaili Sour Soup Featured at World Brand Moganshan Summit, Highlighting Qiandongnan's Growth ProspectsKAILI, China, May 19, 2026 (GLOBE NEWSWIRE) -- At the 2026 World Brand Moganshan Summit held recently, Qiandongnan Miao and Dong Autonomous Prefecture in Guizhou Province showcased its signature Kaili sour soup, promoting the region's cultural heritage, industrial development and business potential to investors and guests from across China.
Deeper reading insights unlocked: Rakuten Kobo and StoryGraph announce integrationComing in June, Kobo users can track their reading progress easier than ever with automatic StoryGraph sync
Fangzhou Ranked among 2025 Guangzhou AI Innovation “Most Promising Enterprises” for AI‑Powered Chronic Disease ServicesGUANGZHOU, China, May 19, 2026 (GLOBE NEWSWIRE) -- Fangzhou Inc. (“Fangzhou” or the “Company”) (HKEX: 06086), a leading provider of AI‑driven Internet healthcare solutions, was invited to attend the 2026 Guangzhou Artificial Intelligence and Intelligent Autonomous Systems Innovation Development Promotion Conference (the “Conference”), where the Company was recognized for its technological innovation in “AI + chronic disease services.”
AMC Robotics Reports First Quarter 2026 Financial ResultsReports Net Income of $146K in First Quarter 2026, Compared to Net Loss in Prior-Year Period; Gross Margin Expands to 86%
QDRO Acquisition Corp. Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing May 20, 2026New York, NY, May 18, 2026 (GLOBE NEWSWIRE) -- QDRO Acquisition Corp. (
NASDAQ: QADRU) (the “Company”) announced today that, commencing May 20, 2026, holders of the units sold in the Company’s initial public offering may elect to separately trade the Company’s Class A ordinary shares and warrants included in the units. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. The Class A ordinary shares and warrants that are separated will trade on the Nasdaq under the symbols “QADR” and “QADRW,” respectively. Those units not separated will continue to trade on the Nasdaq under the symbol “QADRU.”
FWRD SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws ViolationsNEW YORK, May 18, 2026 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds investors of its investigation on behalf of Forward Air Corporation (“Forward Air” or the “Company”) (
NASDAQ:FWRD) investors concerning the Company’s and/or members of its senior management’s possible violation of the federal securities laws or other unlawful business practices.
GAIA SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws ViolationsNEW YORK, May 18, 2026 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds investors of its investigation on behalf of Gaia, Inc. (“Gaia” or the “Company”) (
NASDAQ:GAIA) investors concerning the Company’s and/or members of its senior management’s possible violation of the federal securities laws or other unlawful business practices.
Itron Completes Project to Modernize Water Management in Thane, IndiaThane Municipal Corporation Smart Water Metering Project Aims to Improve Leak Detection, Billing Accuracy and Water Distribution Operations
Scientists discover over 1,100 new marine species in landmark Ocean CensusWorld’s largest mission to accelerate species discovery reveals extraordinary new life forms from some of Earth’s most extreme and unexplored environments
CERT SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws ViolationsNEW YORK, May 18, 2026 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds investors of its investigation on behalf of Certara, Inc. (“Certara” or the “Company”) (
NASDAQ:CERT) investors concerning the Company’s and/or members of its senior management’s possible violation of the federal securities laws or other unlawful business practices.
AZTA SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws ViolationsNEW YORK, May 18, 2026 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds investors of its investigation on behalf of Azenta, Inc. (“Azenta” or the “Company”) (
NASDAQ:AZTA) investors concerning the Company’s and/or members of its senior management’s possible violation of the federal securities laws or other unlawful business practices.
WGS SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws ViolationsNEW YORK, May 18, 2026 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds investors of its investigation on behalf of GeneDx Holdings Corp. (“GeneDx” or the “Company”) (
NASDAQ:WGS) investors concerning the Company’s and/or members of its senior management’s possible violation of the federal securities laws or other unlawful business practices.
The Royal Mint and Texas Precious Metals Announce Partnership to Expand Bullion Distribution in the USASHINER, Texas, May 18, 2026 (GLOBE NEWSWIRE) -- The Royal Mint has announced a new distribution partnership with Texas Precious Metals, one of the largest precious metals companies in the United States.
Star Room at Vista del Monte honored for Best Practice/Innovation of the YearSanta Barbara senior living community offers secure, immersive night sky experience for residents
SHAK Investors Have Opportunity to Join Shake Shack Inc. Fraud Investigation with the Schall Law FirmLOS ANGELES, May 18, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Shake Shack Inc. (“Shake Shack” or “the Company”) (
NYSE: SHAK) for violations of the securities laws.
YSS Investors Have Opportunity to Join York Space Systems, Inc. Fraud Investigation with the Schall Law FirmLOS ANGELES, May 18, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of York Space Systems, Inc. (“York” or “the Company”) (
NYSE: YSS) for violations of the securities laws.
Pennant Group to Participate in the 2026 RBC Global Healthcare ConferenceEAGLE, Idaho, May 18, 2026 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (
NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, announced today that it will participate in the upcoming 2026 RBC Global Healthcare Conference on May 20, 2026. John Gochnour, President and Chief Operating Officer, Lynette Walbom, Chief Financial Officer, and Andy Rider, President of Senior Living, will participate in a fireside chat on May 20, 2026 at 9:30 a.m. Eastern Time. A live webcast of the event will be accessible at https://kvgo.com/rbc/the-pennant-group-inc-may-2026.
Global Water Resources Reports Results of Director ElectionPHOENIX, May 18, 2026 (GLOBE NEWSWIRE) -- Global Water Resources Inc., ("the Company"), (
NASDAQ: GWRS), a pure-play water resource management company, announced that the nominees listed in the Proxy Statement, dated March 31, 2026, for the 2026 Annual Meeting of Stockholders ("the Meeting") were selected as Directors of the Company.
Intuitive Machines Announces Two Prime Lunar Reconnaissance ContractsHOUSTON, May 18, 2026 (GLOBE NEWSWIRE) -- Intuitive Machines, Inc. (Nasdaq: LUNR) (“Intuitive Machines”, together with its subsidiaries, the “Company”), a space technology, infrastructure, and services leader, is now the prime contractor for operations of the Lunar Reconnaissance Orbiter Camera (“LROC”), a key instrument aboard NASA's Lunar Reconnaissance Orbiter ("LRO"), and the ShadowCam instrument, a specialized lunar imaging camera on board the Korea Pathfinder Lunar Orbiter that provides visibility in light obscured conditions such as dark and shadowed regions of the Moon.
Statement on Today’s Massachusetts Jury VerdictNEW YORK, May 18, 2026 (GLOBE NEWSWIRE) -- Lowey Dannenberg is pleased to announce that today, after a five week trial, a nine member federal court jury in Boston, Massachusetts awarded a verdict of $63.2 million in damages to the certified class of end-payor purchasers, led by class representative Premera Blue Cross. The class is comprised of third-party payors who indirectly purchased Amitiza and/or AB-rated generic versions of Amitiza (lubiprostone) in 14 states and the District of Columbia from October 1, 2016 through March 31, 2024.
Exyn Announces Closing of its Initial Public OfferingPHILADELPHIA, PA, May 18, 2026 (GLOBE NEWSWIRE) -- Exyn Technologies, Inc. (“Exyn” or the “Company”) (NASDAQ: EXYN, EXYNW), a leader in autonomous mapping and perception-driven navigation for complex, GPS-denied environments, today announced the closing of its initial public offering (the “Offering”) of 2,500,000 units, with each unit consisting of one share of its common stock (the “Common Stock”) and one warrant to purchase one share of its common stock (the “Warrants”) at a public offering price of $7.75 per unit.
Pennant Announces an Acquisition of Senior Living Community in ArizonaEAGLE, Idaho, May 18, 2026 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (
NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice, home care and senior living companies, announces the acquisition of the real estate and operations of an established senior living community, Copper Canyon Memory Care in Tucson, Arizona. The newly acquired community offers memory care services and increases Pennant’s Arizona operations by 40 units.
DRC Congratulates Sarah Eddy, William Savitt, and the Wachtell and Morrison Foerster Trial Team on Their Victory for OpenAI in Musk, et al. v. Altman, et al.OAKLAND, Calif., May 18, 2026 (GLOBE NEWSWIRE) -- DRC congratulates its clients Sarah Eddy, William Savitt, and the entire trial team at Wachtell, Lipton, Rosen & Katz and Morrison Foerster for their successful defense on behalf of Sam Altman, Greg Brockman, the OpenAI Foundation, and OpenAI Group PBC in Musk, et al. v. Altman, et al., Case No. 4:24-cv-04722 (N.D. Cal.). Following a three-week trial, the jury deliberated for less than two hours before reaching a unanimous verdict in favor of OpenAI. Elon Musk brought claims against OpenAI and two of its founders, Sam Altman and Greg Brockman, for breach of charitable trust and unjust enrichment. Musk alleged that Altman and Brockman broke promises to him about the non-profit structure of OpenAI. The Defense showed that no such promises were made, that Musk himself wanted to turn OpenAI into a for-profit, that OpenAI remains a non-profit, and that Musk’s claims were barred by the statute of limitations. Musk also brought a claim for aiding and abetting a breach of charitable trust against Microsoft. After three weeks of trial, the jury deliberated for about ninety minutes before finding that both OpenAI and Microsoft had proven their statute of limitations defense for all claims. Because the Defense prevailed on the statute of limitations, which was the very first question on the verdict form, the jury did not need to consider the merits of Musk’s claims. Judge Yvonne Gonzalez Rogers adopted the jury’s findings and promptly dismissed all of Musk’s claims from the bench. DRC congratulates Defense counsel Sarah Eddy, William Savitt, Bradley Wilson, Nathaniel Cullerton, Randall Jackson, Steven Winter, Kelsey Borenzweig, and Zachary David of Wachtell, Lipton, Rosen & Katz, and William Frentzen, Jordan Eth, David Wiener, and Camila Tapernoux of Morrison Foerster. DRC assisted the trial team with jury research, jury selection, trial graphics, at-trial technology support, and trial strategy consulting.
Egnyte Targets Data Fragmentation with Automated Email and Content GovernanceEmail Capture centralizes siloed communications repositories, and new AEC capabilities ensure business-critical decisions are searchable, secure, and ready for AI
Blaze Pizza Partners With Folds of Honor for Memorial Day Give-Back Initiative$1 From Every 11-Inch Pizza Sold on May 25 Will Support Educational Scholarships for Families of Fallen and Disabled Heroes
Iron Dome Acquisition I Corp. Announces Closing of $150 Million Initial Public OfferingNew York, New York, May 18, 2026 (GLOBE NEWSWIRE) -- Iron Dome Acquisition I Corp. (the “Company”), a special purpose acquisition company, today announced the closing of its initial public offering of 15,000,000 units at a price of $10.00 per unit. The units began trading on the Nasdaq Global Market (“Nasdaq”) under the ticker symbol “IDACU” on May 15, 2026. Each unit consists of one Class A ordinary share and one-half of one redeemable warrant of the Company. Each whole warrant entitles the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share, subject to certain adjustments. Once the securities comprising the units begin separate trading, the Company expects that its Class A ordinary shares and warrants will be listed on Nasdaq under the symbols “IDAC” and “IDACW,’’ respectively.
Bragar Eagel & Squire, P.C. Reminds Atara Biotherapeutics, Inc. Investors They Have Until May 22nd to Seek Lead Plaintiff Role in Class Action LawsuitBragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Atara (ATRA) To Contact Him Directly To Discuss Their Options
UK sends largest ever business delegation to the US for Greater Together Los AngelesLOS ANGELES, May 18, 2026 (GLOBE NEWSWIRE) -- His Majesty the King sent a personal message of support to more than 250 British business and cultural leaders preparing to fly to Los Angeles this weekend for Greater Together LA, the largest ever UK trade and investment mission to the United States.
U-BX Technology Ltd. Announces Effective Date of Reverse Stock SplitNEW YORK, May 18, 2026 (GLOBE NEWSWIRE) -- U-BX Technology Ltd. (the "Company" or "U-BX") (
NASDAQ:UBXG), a leading company providing value-added services using artificial intelligence-driven technology to businesses within the insurance industry, including insurance carriers and brokers, today announced that it has resolved to effect a reverse stock split of the Company’s class A ordinary shares and class B ordinary shares and has determined the ratio to be 1-for-25. At the Company’s annual meeting of shareholders held on November 4, 2025, the Company’s shareholders approved a reverse stock split at a ratio of not less than 1-for-2 and not more than 1-for-250 and granted the Company’s Board of Directors the authority to determine the exact split ratio. On May 12, 2026, the Company’s Board of Directors determined the ratio to be 1-for-25. U-BX’s class A ordinary shares will begin trading on an adjusted basis giving effect to the reverse stock split on May 22, 2026 under the existing ticker symbol “UBXG”. The new CUSIP number of the Company’s class A ordinary shares will be G9161K120.
Cullinan Therapeutics to Present Initial Clinical Data for CLN-978 in Treatment-Refractory Rheumatoid Arthritis and Systemic Lupus Erythematosus at EULAR 2026 CongressCAMBRIDGE, Mass., May 18, 2026 (GLOBE NEWSWIRE) -- Cullinan Therapeutics, Inc. (Nasdaq: CGEM), a clinical-stage biopharmaceutical company accelerating potential first- or best-in-class, high-impact therapies in autoimmune diseases and cancer, today announced that initial clinical data from two ongoing Phase 1 studies evaluating CLN-978, a subcutaneously administered CD19xCD3 T cell engager, will be presented at the European Alliance of Associations for Rheumatology (EULAR) European Congress of Rheumatology being held June 3-6, 2026 in London, United Kingdom.
Antalpha Announces Strategic Expansion Into AI InfrastructureSINGAPORE, May 18, 2026 (GLOBE NEWSWIRE) -- Antalpha (
NASDAQ: ANTA) (“Antalpha” or the “Company”), today announced a broader strategic expansion into AI infrastructure and intelligent routing systems as an additional growth vector aligned with the Company’s evolving long-term technology roadmap.
IPAX-2 Study of TLX101-Tx in First-line Glioblastoma Completes Enrolment and Confirms DosingMELBOURNE, Australia and INDIANAPOLIS, May 19, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces that the IPAX-2 study1 of TLX101-Tx (¹³¹I-iodofalan) in patients with newly diagnosed glioblastoma has completed patient enrolment. No dose-limiting toxicities (DLTs) have been observed to date, including with two doses of 5GBq (total administered activity of 10GBq), the maximum administered dose in the study.
Bragar Eagel & Squire, P.C. Urges Coty, Inc. Stockholders with Significant Losses to Contact the Firm Regarding Their Rights Before May 22ndBragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Coty To Contact Him Directly To Discuss Their Options
Destinations Career Academy of New Mexico (NMDCA) Graduates More Than 220 StudentsClass of 2026 spans 24 of New Mexico’s 33 counties, representing the full diversity of communities across the state
Dave’s Hot Chicken Serves Up More of What Fans Love with the Launch of Dave’s Big TrioDave’s Bites, Hot Mozz, and fan-favorite Mini Sliders Served Together Beginning May 19
Wave Life Sciences Announces Positive Update on RestorAATion-2 Trial: WVE-006 (GalNAc-RNA Editing) Achieves MZ-Like Phenotype Across Both Biweekly and Monthly DosingData reinforce WVE-006’s potential to address both lung and liver manifestations of AATD with a durable, convenient, and safe therapy capable of recapitulating the protective MZ-like phenotype with monthly dosing
Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)RESEARCH TRIANGLE PARK, N.C., May 18, 2026 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (
NASDAQ:FENC) (TSX:FRX) (“Fennec” or the “Company”), a specialty pharmaceutical company, today announced that on May 11, 2026, the Compensation Committee of the Company’s Board of Directors approved the grant of stock option awards (“Stock Options”) to purchase an aggregate of 50,000 of the Company’s common shares to three new non-executive employees of the Company with a grant date of May 18, 2026 under the Company’s 2026 Equity Inducement Plan (the “Inducement Plan”). The Stock Options consist of incentive stock options to purchase an aggregate of 49,141 shares and nonqualified stock options to purchase an aggregate of 859 shares. The Stock Options were granted as inducements material to the employees entering into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4).
HERCULES CAPITAL DEADLINE MAY 19th: Bragar Eagel & Squire, P.C. Urges Hercules Capital Investors with Large Losses to Contact the Firm Before May 19th Regarding Their RightsBragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Hercules Capital (HTGC) To Contact Him Directly To Discuss Their Options
Certara to Participate in Upcoming Investor ConferencesRADNOR, Pa., May 18, 2026 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that Company management will participate in the following investor conferences:
Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)WALTHAM, Mass., May 18, 2026 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of transformative therapies for patients living with autoimmune diseases, today announced that on May 15, 2026 (the “Grant Date”), the Compensation Committee of the Company’s Board of Directors granted an aggregate of 51,075 restricted stock units of the Company’s common stock (“RSUs”) to newly hired employees of the Company as an inducement material to such employees’ entry into employment with the Company, in accordance with Nasdaq Listing Rule 5635(c)(4) (the “Inducement Grant”).
